Media Summary: Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, talks on the ... What clinical trials led to updates in the treatment strategies for Dr. Bhavana Pothuri provides an overview of

Latest Developments In Immunotherapy For Advanced Recurrent Endometrial Cancer - Detailed Analysis & Overview

Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, talks on the ... What clinical trials led to updates in the treatment strategies for Dr. Bhavana Pothuri provides an overview of Ilana Cass, MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, discusses subgroup analyses from the RUBY trial ... Ritu Salani, MD, MBA, UCLA Health, Los Angeles, CA, discusses the role of Dr. Susana Banerjee and Dr. Shira Peleg Hasson provide an overview of their commentary, “Top

Matthew Powell, MD, the Ira C. and Judith Gall Distinguished Professor of Obstetrics and Gynecology, Division of Gynecologic ... Shannon Westin, MD, FASCO, The University of Texas MD Anderson Ilana Cass, MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, comments on the evolving landscape of Shannon Westin, MD, University of Texas MD Anderson

Photo Gallery

Latest developments in immunotherapy for advanced/recurrent endometrial cancer
Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines
Advances in Endometrial Cancer Treatment (2025)
Time to next treatment by age in the RUBY trial of dostarlimab in endometrial cancer
Role of immunotherapy in advanced endometrial cancer: recent developments and future directions
Exploring Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions
Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gyne...
FDA Approves New Immunotherapy Treatment for Endometrial Cancer
The evolving standard of care for advanced/recurrent endometrial cancer
What are the 2023 Top Advances in Immunotherapy for Endometrial Cancer Research?
KEYNOTE-100 update: pembrolizumab in patients with advanced recurrent ovarian cancer
Understanding Immunotherapy for Endometrial Cancer | iCliniq
Sponsored
Sponsored
View Detailed Profile
Latest developments in immunotherapy for advanced/recurrent endometrial cancer

Latest developments in immunotherapy for advanced/recurrent endometrial cancer

Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, talks on the ...

Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines

Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines

What clinical trials led to updates in the treatment strategies for

Sponsored
Advances in Endometrial Cancer Treatment (2025)

Advances in Endometrial Cancer Treatment (2025)

Dr. Bhavana Pothuri provides an overview of

Time to next treatment by age in the RUBY trial of dostarlimab in endometrial cancer

Time to next treatment by age in the RUBY trial of dostarlimab in endometrial cancer

Ilana Cass, MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, discusses subgroup analyses from the RUBY trial ...

Role of immunotherapy in advanced endometrial cancer: recent developments and future directions

Role of immunotherapy in advanced endometrial cancer: recent developments and future directions

Ritu Salani, MD, MBA, UCLA Health, Los Angeles, CA, discusses the role of

Sponsored
Exploring Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions

Exploring Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions

Download resources and collect credit: https://www.ceconcepts.com/wcv-130-encore/

Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gyne...

Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gyne...

Dr Floor J Backes from The James

FDA Approves New Immunotherapy Treatment for Endometrial Cancer

FDA Approves New Immunotherapy Treatment for Endometrial Cancer

The FDA's approval of a

The evolving standard of care for advanced/recurrent endometrial cancer

The evolving standard of care for advanced/recurrent endometrial cancer

Advancing

What are the 2023 Top Advances in Immunotherapy for Endometrial Cancer Research?

What are the 2023 Top Advances in Immunotherapy for Endometrial Cancer Research?

Dr. Susana Banerjee and Dr. Shira Peleg Hasson provide an overview of their commentary, “Top

KEYNOTE-100 update: pembrolizumab in patients with advanced recurrent ovarian cancer

KEYNOTE-100 update: pembrolizumab in patients with advanced recurrent ovarian cancer

Ursula Matulonis, MD, Dana-Farber

Understanding Immunotherapy for Endometrial Cancer | iCliniq

Understanding Immunotherapy for Endometrial Cancer | iCliniq

Endometrial cancer

Dr Powell on the FDA Approval of Dostarlimab Plus Chemo in Advanced/Recurrent Endometrial Cancer

Dr Powell on the FDA Approval of Dostarlimab Plus Chemo in Advanced/Recurrent Endometrial Cancer

Matthew Powell, MD, the Ira C. and Judith Gall Distinguished Professor of Obstetrics and Gynecology, Division of Gynecologic ...

Olaparib and durvalumab combination therapy for advanced endometrial cancer

Olaparib and durvalumab combination therapy for advanced endometrial cancer

Shannon Westin, MD, FASCO, The University of Texas MD Anderson

Optimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management

Optimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management

Guest: Ann Klopp, M.D., Ph.D.

Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

Updates on

New Treatments for Advanced Uterine Cancer Explained

New Treatments for Advanced Uterine Cancer Explained

Looking for

Current treatment options in advanced/recurrent endometrial cancer

Current treatment options in advanced/recurrent endometrial cancer

Current

What developments have there been in endometrial cancer treatment?

What developments have there been in endometrial cancer treatment?

Ilana Cass, MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, comments on the evolving landscape of

Durvalumab & olaparib as maintenance in patients with MMR-proficient advanced endometrial cancer

Durvalumab & olaparib as maintenance in patients with MMR-proficient advanced endometrial cancer

Shannon Westin, MD, University of Texas MD Anderson